Techrockies.com
Search
Recursion Ups Series A To $15.05M
Salt Lake City-based Recursion Pharmaceuticals announced today that it has raised an additional $2.15M in funding as part of its Series A, bringing the total raised in its round to $15.05M. The additional funding came from individual angels, along with Felicis Ventures. Recursion Pharmaceuticals had previously announced the involvement of Lux Capital, Obvious Ventures, Epic Ventures, Data Collective, AME Cloud Ventures, Wild Basin Investments, and others in the initial tranche.Recursion is developing drug discovery technology for novel drug screening, aimed at identifying pharmaceuticals to treat rare genetic diseases and other conditions. The company has now raised a total of $19M.
posted on Tuesday, November 22, 2016 (Link to more information)

Related companies:
Recursion Pharmaceuticals, LLC

Related stories:
> Recursion Pharmaceuticals Raises $60M
> Recursion Pharmaceuticals Names COO
> Recursion Pharmaceuticals Adds Scientific Advisor
> Recursion Pharmaceuticals Gets $12.9M To Apply AI To Drug Discovery
> Amazon Launches Arizona Cardinals Series

Techrockies.com Home